Insights

Childhood obesity risk factors in Mexican American children include age and maternal BMI. Prolonged bottle feeding, less outdoor play, and sugary drinks are significant risk factors. Family involvement can help mitigate these risks.

Area of Science:

  • Pediatric Health
  • Nutritional Epidemiology
  • Public Health

Background:

  • Childhood obesity is a growing public health concern, particularly in minority populations.
  • Identifying specific risk factors in Mexican American children is crucial for targeted interventions.
  • The Ecological Model of Growth provides a framework for understanding multifaceted influences on child development.

Purpose of the Study:

  • To explore risk factors associated with obesity in Mexican American children.
  • To compare risk factors between obese and normal-weight Mexican American children.
  • To inform evidence-based practices for nurses in reducing obesity-related behaviors.

Main Methods:

  • Cross-sectional descriptive study design comparing obese and normal-weight Mexican American children.
  • Data collected from 55 mother-child dyads in South Texas using anthropometrics, dietary intake, home environment, maternal stress, and acculturation measures.
  • Statistical analyses included independent sample t tests, chi-square tests, Fisher exact tests, and hierarchical logistic regression.

Main Results:

  • Childhood obesity positively correlated with children's age and maternal body mass index (BMI).
  • Significant differences observed in prolonged bottle feeding, outdoor play duration, and fruit drink consumption between weight groups.
  • Host and agent factors identified as key differentiators between normal-weight and obese children.

Conclusions:

  • Maternal BMI and child's age are significant predictors of childhood obesity.
  • Dietary habits (fruit drinks) and lifestyle factors (bottle feeding, outdoor play) play a critical role.
  • Involving family in nutrition, childcare, and physical activities can mitigate obesity risks.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
815
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
173
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
136
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
611
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
202